Here are some of the top life sciences news stories and tweets from this week (February 24th-28th 2014). New SWOT analysis: generics will keep dominating the insomnia market, and eroding sales will be a drag on potential 1st in class suvorexant — Cortellis (@Cortellis) February 26, 2014 Calithera’s CB-839 enters US phase I trials for […]
written on 28.02.2014
Top Life Sciences News Stories Vol. 36
